Desferrioxamine (DFO) is a chelating agent for the treatment of iron overload with well recognised ocular and ototoxicity. This case report illustrates an optic neuropathy in DFO ocular toxicity undetected on slitlamp biomicroscopy examination but illustrated by optical coherence tomography (OCT).
A 74-year-old female myelofibrosis patient weighing 10.5 stones on 1.5 g of subcutaneous DFO presented with deteriorating vision associated with moderate neurosensory deafness. DFO toxicity was diagnosed and treatment ceased.
At presentation, visual acuity had reduced from 6/6 to 6/12 in the right and 6/9 in the left. Ishihara was reduced with 2/13 plates identified. Humphrey 24-2 visual field assessments showed bilateral peripheral losses. Slitlamp biomicroscopy was normal. A relative afferent papillary defect was absent.
OCT imaging of the macula and retinal nerve fibre layers (RNFLs; Figure 1 ) were obtained with a Stratus OCT machine (Carl Zeiss Meditec Inc., Dublin, CA, USA). Macula OCT scan had a normal foveal dip with no signs of fluid or retinal thickening. OCT RNFL scans were obtained with reference planes at 150 mm above the level of RPE revealing a thickened OCT RNFL.
Over 10 months, visual acuity (6/7.5 bilateral) and colour vision (13/13 bilateral) improved with a reduction in OCT RNFL thickness.
Peripapillary atrophy and fine pigmentary changes in both posterior poles were now visible.
Discussion DFO ocular and ototoxicity in our patient was in keeping with descriptions from previous reports. [1] [2] [3] In 1984, Lakhanpal et al 2 reported retinal pigmentary degeneration and a presumed optic neuropathy with DFO. Interestingly, he presented patients with presumed retrobulbar optic neuropathy based on the central scotomas and colour vision abnormalities experienced. 2 Our case report supports the suggestion that previously undetected optic neuropathy may be part of the DFO ocular toxicity spectrum.
Often DFO ocular toxicity is diagnosed by a clinical history and a reduction in visual function. Subtle early signs makes detecting and screening for DFO toxicity difficult. Monitoring disease progression is hindered by late pigmentary changes emerging after visual function recovery. Hence, non-invasive OCT imaging; a welltolerated scan; may prove useful in early detection and monitoring recovery. To the best of our knowledge, this is the only case to illustrate DFO optic neuropathy on OCT.
The corresponding author has the right to grant on behalf of all authors, and does grant on behalf of all authors, an exclusive licence Cardenolides, also known as cardiac glycosides, are a group of C 23 steroids produced in nature by several plant families. These natural toxins protect plants and insects from predation. In humans, they have a cardiotonic activity, which is the basis for much of their pharmacological uses. A receptor for cardenolides is the integral membrane protein Na þ /K þ -ATPase. Cardenolides bind the enzyme region of this protein at the endothelial cell surface and inhibit the pump's activity. 2 Asclepias fruticosa is a small perennial shrub about 1-1.5 m in height, containing a milky latex with cardiac glycosides and proteolytic activity (Figure 1) . 3 Plants of the genus Asclepias (milkweed family) are widely distributed, mainly in the tropics and subtropics, and are well known causes of death in sheep and cattle in open-range grazing. 4, 5 It is common in grassland and is often planted in gardens because it attracts butterflies.
There has been one previous case report describing painless blurring of vision and corneal oedema following contact with the milky latex of A. curassavica.
1 Herein, we describe the self-limited effects of A. fruticosa latex components on the cornea. We also discuss the mechanism of endothelial cell toxicity and provide an update on the current literature on the regulation of the Na þ /K þ -ATPase activity and pump function in corneal endothelial cells.
Case report
A previously healthy 73-year-old farmer presented to our clinic complaining of redness and blurred vision in both eyes (right worse than left). The previous day, he handled the milky latex of an Asclepias shrub and then rubbed his eyes. He did not have any ocular discomfort. On examination, best-corrected visual acuity was counting fingers on the right and 20/40 on the left. Slit-lamp microscopy showed conjunctival hyperemia, stromal corneal oedema with Descemet's folds greater on the right, and a moderate cataract in both eyes (Figures  2a and b) . The corneal epithelium was intact. Anterior chamber was quiet with no appreciable flare. Intraocular pressure and posterior segment examination were within normal limits. Both eyes were flushed with saline. Topical dexamethasone 0.1% eye drops and artificial tears (four times a day) were prescribed. At 3 days after exposure, symptoms and clinical signs showed marked improvement. At 2 weeks after presentation, corneal oedema resolved with a best-corrected vision of 20/40 on the right and 20/30 on the left, consistent with moderate nuclear sclerotic changes. At 9 months after presentation, the patient's corneas remained clear with stable vision (Figure 3 ).
Discussion
The plants of the Asclepiadaceae family are known to contain toxic cardiac glycosides in their latex, stems, leaves, and roots. Cardiac glycosides function clinically by inhibiting the enzyme Na þ /K þ -ATPase. 6 Normal functioning of corneal endothelial Na þ /K þ -ATPase pump is needed to maintain corneal transparency.
7
Cardenolides are capable of penetrating the human cornea without major injury to the epithelium. 1 Topical administration of digitoxin has been shown to cause corneal oedema by inhibiting endothelial Na þ /K þ -ATPase. 8 Similar ocular changes were noted in a patient with systemic digoxin toxicity. 9 Isolated corneal oedema developed in our patient several hours after the ocular surface had come into contact with traces of the milky latex of an Asclepias 
